Associations between obesity severity and medical comorbidities for children with obesity in low intensity hospital

Maya Tsao-Wu1, Ronald J Williams2, Helen M Hendy3

  • 1College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA, United States.

Insights

Children with Class III obesity face higher risks for serious medical conditions like hypertension and type 2 diabetes. Early, intensive interventions are crucial to prevent severe obesity and related comorbidities.

Area of Science:

  • Pediatrics
  • Public Health
  • Endocrinology

Background:

  • Childhood obesity prevalence has surged in the U.S.
  • Limited research addresses medical comorbidities associated with obesity severity.
  • Understanding comorbidities can inform prevention and intervention strategies.

Purpose of the Study:

  • To investigate the associations between obesity severity levels and specific medical comorbidities in children.
  • To analyze the relationship between obesity severity and blood pressure, and the prevalence of diagnoses like hypertension and type 2 diabetes.

Main Methods:

  • Retrospective chart review of 2038 children at a Pediatric Weight Management Clinic.
  • Linear regression to assess obesity severity and blood pressure percentiles.
  • Logistical regression to evaluate obesity severity and medical diagnoses.

Main Results:

  • Class III obesity was linked to significantly higher risks for five of seven medical conditions.
  • Children with Class III obesity had elevated systolic and diastolic blood pressure scores.
  • Higher odds of hypertension, type 2 diabetes, and obstructive sleep apnea were observed in severe obesity.

Conclusions:

  • Severe obesity (Class III) is associated with increased risk of critical medical comorbidities.
  • Further research is needed on intensive behavioral interventions before obesity reaches Class III severity.
  • Proactive interventions may prevent severe obesity and its associated health complications in children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
202
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
173
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
136
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
611
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
198